English | 简体中文 | 繁體中文 | 한국어
Share:
Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2019

DUBLIN - November 9, 2018 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for the second quarter of fiscal year 2019 on Tuesday, November 20, 2018. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at http://newsroom.medtronic.com. The news release will include summary financial information for the company's second quarter of fiscal year 2019, which ended on Friday, October 26, 2018.

Medtronic will host a webcast at 7:00 a.m. CST to discuss financial results for its second quarter of fiscal year 2019. The webcast can be accessed at http://investorrelations.medtronic.com on November 20, 2018.

Within 24 hours of the webcast, a replay and transcript of the prepared remarks will be available by clicking on the Investor Events link at http://investorrelations.medtronic.com.

Looking ahead, Medtronic plans to report its fiscal year 2019 third and fourth quarter financial results on Tuesday, February 19, 2019, and Thursday, May 23, 2019, respectively. Medtronic plans to report its fiscal year 2020 first quarter on Tuesday, August 20, 2019. Confirmation and additional details will be provided closer to the specific event.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

Contacts:
Fernando Vivanco
Public Relations
+1-763-505-3780

Ryan Weispfenning
Investor Relations
+1-763-505-4626





This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medtronic plc via Globenewswire

Copyright © Thomson Reuters 2019. All rights reserved.
Press Releases
Lubrizol Engineered Polymers Signs Agreement with The Institute of Chemical Technology in India  
Mar 22, 2019 20:29 ET
Nokia comments on market rumors related to its annual report on Form 20-F  
Mar 22, 2019 15:46 ET
Klövern AB (publ): Klövern's Annual report and Sustainability report for 2018  
Mar 22, 2019 14:36 ET
Lubrizol Engineered Polymers Signs Agreement with The Institute of Chemical Technology in India  
Mar 22, 2019 13:00 ET
Hexagon Composites ASA: Mandatory notification of trade - options  
Mar 22, 2019 07:55 ET
Novartis plans for Alcon spin-off on April 9, 2019  
Mar 22, 2019 07:00 ET
INGREDION INCORPORATED DECLARES QUARTERLY DIVIDEND OF $0.625 PER SHARE  
Mar 21, 2019 01:59 ET
Verisk Joins Effort to Fight Patent Trolls  
Mar 19, 2019 23:31 ET
Lubrizol Expands Again with New TPU Line in Songjiang  
Mar 19, 2019 23:29 ET
Lubrizol Completes Acquisition of Laboratoire Phenobio  
Mar 18, 2019 21:29 ET
More News >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: